This site uses cookies to confirm your selections for future visits. By using the site without changing settings, you agree to our use of cookies.

Catalio Global Innovative Healthcare Long/Short UCITS Fund

Overview

  • Catalio Capital Management was founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein to invest in the next generation of category-defining life sciences companies around the globe.
  • Catalio's multi-strategy platform's three pillars - Private Equity, Private Credit, Public Equities – supports compelling life science investment opportunities at all stages of development. The investment team is supplemented by Catalio Venture Partners, a group of 44 world-renowned serial scientist-entrepreneurs providing investment teams with a truly differentiated view on disruptive trends, emerging strategies and next generation therapies in healthcare and life sciences and assisting them in understanding and identifying what constitutes breakthrough biomedical technology.
  • The firm naturally performs an in-depth ESG Assessment, achieved by strong technical diligence incorporating scientific/clinical expertise and financial analysis across disease states, therapeutic categories, and pricing strategies.

Investment Strategy

  • The Catalio Global Innovative Healthcare Long/Short UCITS Fund is a fundamentals-driven long/short equity strategy with a focus on global healthcare equities across sub-sectors: innovative drugs, devices, diagnostics and data.
  • The strategy, with a variable long-net position, centres around the identification of mis-priced risks in clinical strategy, regulatory strategy, IPs, manufacturing and commercial strategy while focusing on an in-depth, bottom-up, fundamental research.
  • A minimum 65% of longs committed to Environmental and Social Characteristics and an investment process centred around monitoring and measuring impact, make it an SFDR Article 8 Fund.

Biography

Ben Snedeker, Partner and Co-Head of Public Equities

Ben Snedeker is a Partner and Co-Head of Public Equities at Catalio Capital Management, LP. Ben has been Sector Head Therapeutics at HealthCor Management and PointState Capital and began his investing career as a therapeutics analyst and portfolio manager at D.E. Shaw & Co. on the long-short healthcare equities team. Ben was also an Associate Principal at McKinsey & Company in the Global Pharmaceuticals and Medical Products practice and a co-founder of McKinsey's Philadelphia office.

Pricing

Prices and performance by share class
Fund name Class ISIN Ccy NAV Daily change % change MTD Price date
Catalio Global Innovative Healthcare Long/Short UCITS Fund B EUR (ACC) IE000J1ZY0G8 EUR 1022.26 -8.34 -0.81% 1.61% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund E EUR (ACC) IE0002MSSRH2 EUR 1044.37 -8.49 -0.81% 1.65% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund E USD (ACC) IE000OZB0OS2 USD 1071.19 -8.70 -0.81% 1.70% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund E GBP (ACC) IE00007P7F44 GBP 1070.00 -8.75 -0.81% 1.66% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund E CHF (ACC) IE0002UES685 USD 1022.95 -8.36 -0.81% 1.60% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund I1 EUR (ACC) IE000WR04IS5 EUR 1040.54 -8.47 -0.81% 1.63% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund I1 USD (ACC) IE000XOAKHW9 USD 1068.17 -8.69 -0.81% 1.68% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund I1 GBP (ACC) IE000KALYAU2 GBP 1059.16 -6.95 -0.65% 1.37% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund I2 EUR (ACC) IE000PALSCI4 EUR 1028.42 -8.37 -0.81% 1.64% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund I2 USD (ACC) IE000YHV61G0 USD 1066.98 -8.68 -0.81% 1.69% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund I2 GBP (ACC) IE000DTJ28K5 GBP 1065.09 -8.70 -0.81% 1.66% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund P EUR (ACC) IE0002A2NNY9 EUR 1047.88 -8.51 -0.81% 1.66% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund U EUR (ACC) IE00005DNNE1 EUR 1044.22 -8.47 -0.80% 1.66% 3/11/2026
Catalio Global Innovative Healthcare Long/Short UCITS Fund S USD (ACC) IE000E9KFFC7 USD 1080.01 -8.76 -0.80% 1.72% 3/11/2026

Documents

Prospectus and Supplements
  • Performance Scenarios ⋅ EN
  • IAM Investments ICAV - DE Prospectus ⋅ EN
  • IAM Investments ICAV - OFR UK Country Supplement ⋅ EN
  • Catalio Fund supplement ⋅ EN
  • IAM Investments ICAV Prospectus ⋅ EN
Financial Statements
  • IAM Investments ICAV Annual Report September 2025 ⋅ EN
  • IAM Investments AIF ICAV 30 June 2025 ⋅ EN
  • IAM Investments ICAV Interim 31 March 2025 ⋅ EN
Key Information Document (KID)
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class B EUR (ACC) ⋅ EN ⋅ IT
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class B SEK (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class E CHF (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class E EUR (ACC) ⋅ EN ⋅ ES
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class E USD (ACC) ⋅ EN ⋅ ES
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I1 EUR (ACC) ⋅ EN ⋅ ES
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I1 SEK (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I1 USD (ACC) ⋅ EN ⋅ ES
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I2 EUR (ACC) ⋅ EN ⋅ ES
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I2 SEK (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I2 USD (ACC) ⋅ EN ⋅ ES
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class M USD (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class P EUR (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class S USD (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class U EUR (ACC) ⋅ EN ⋅ DE
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class U USD (ACC) ⋅ EN
Key Investor Information Document (KIID)
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class E GBP (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class I2 GBP (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class E EUR (ACC) ⋅ EN
  • Catalio Global Innovative Healthcare Long/Short UCITS Fund- Class E USD (ACC) ⋅ EN

Subscription documentation available upon request. Please send us an email for more information.

For details on the Carne Global Fund Managers (Ireland) Limited, the manager of the IAM Investments ICAV, remuneration policy please click here.

Newsletters

SFDR Sustainable Finance Disclosures Regulation,
please click here to open the document: SFDR

International Asset Management is authorised and regulated by the Financial Conduct Authority. Registered Office: 11a Regent Street, London, SW1Y 4LR. Registered in England No. 2355655. VAT Registration No. 532 4129 73. Legal Disclaimer.
Privacy Notice